Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The SK bioscience company strengthens its global presence through participation in major international bio events.
May 21, 2025
By: Rachel Klemovitch
Assistant Editor
IDT Biologika, a Germany-based CDMO and a subsidiary of SK bioscience, is accelerating its efforts to explore new business opportunities and strengthen its presence as a global CDMO through major international industry events.
IDT Biologika recently participated in BioProcess International Europe (BPI Europe), held in Germany earlier this month. Federico Pollano, Chief Commercial Officer, and Dr. Nanette Schlatermund, Senior Expert Business Development, attended the event in person.
At the event, the company showcased its tailored end-to-end services for the development and manufacturing of viral vaccines, gene & immune therapeutics, and aseptic fill-finish of sterile injectables. The company also shared successful partnership cases, underscoring its proven capabilities.
Also, in March, IDT Biologika took part in DCAT Week 2025 in New York City, USA.
During the event, the company hosted high-level meetings in a dedicated suite with senior leadership, including Co-CEO Dr. Sally Choe, CCO Federico Pollano, and Dr. Lifeng He, Global Head of Business Development.
Additionally, the company is scheduled to attend the BIO International Convention (BIO US), taking place in Boston from June 16 to 19.
The company recorded positive earnings in both Q4 2024 and Q1 2025, contributing to the financial stability of SK bioscience.
This year, IDT Biologika aims to exceed approximately $294.86 million in annual revenue and achieve a turnaround to profitability by enhancing operational efficiency and securing new business development.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
